These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203 [TBL] [Abstract][Full Text] [Related]
3. Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture. Rajão DS; Pérez DR Front Microbiol; 2018; 9():123. PubMed ID: 29467737 [TBL] [Abstract][Full Text] [Related]
4. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection. Jang YH; Seong BL Expert Opin Drug Discov; 2020 Dec; 15(12):1441-1455. PubMed ID: 32783765 [TBL] [Abstract][Full Text] [Related]
6. Universal influenza vaccines: from viruses to nanoparticles. Wang Y; Deng L; Kang SM; Wang BZ Expert Rev Vaccines; 2018 Nov; 17(11):967-976. PubMed ID: 30365905 [TBL] [Abstract][Full Text] [Related]
7. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens. Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397 [TBL] [Abstract][Full Text] [Related]
10. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice. Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines. Lim CML; Komarasamy TV; Adnan NAAB; Radhakrishnan AK; Balasubramaniam VRMT Influenza Other Respir Viruses; 2024 Mar; 18(3):e13276. PubMed ID: 38513364 [TBL] [Abstract][Full Text] [Related]
12. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice. Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985 [TBL] [Abstract][Full Text] [Related]
13. Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics. Vogel OA; Manicassamy B Front Microbiol; 2020; 11():135. PubMed ID: 32117155 [TBL] [Abstract][Full Text] [Related]
14. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses. Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P J Virol; 2017 May; 91(9):. PubMed ID: 28179535 [TBL] [Abstract][Full Text] [Related]
15. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells. Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ mBio; 2019 Mar; 10(2):. PubMed ID: 30862743 [TBL] [Abstract][Full Text] [Related]
16. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines. Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H mBio; 2019 Sep; 10(5):. PubMed ID: 31530680 [TBL] [Abstract][Full Text] [Related]
17. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
18. Progress towards the Development of a Universal Influenza Vaccine. Wang WC; Sayedahmed EE; Sambhara S; Mittal SK Viruses; 2022 Jul; 14(8):. PubMed ID: 36016306 [TBL] [Abstract][Full Text] [Related]
19. Progress on adenovirus-vectored universal influenza vaccines. Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176 [TBL] [Abstract][Full Text] [Related]
20. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains. Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]